$7.03
-0.28-3.83%
Ult. Agg.: Oct 21, 4:00 PM
$7.03
-0.28-3.83%
Phathom Pharmaceuticals (PHAT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Phathom Pharmaceuticals (PHAT) ha pubblicato l'ultima guidance il luglio 30, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $310M - $325M per il periodo.
Rispetto alle previsioni precedenti, Phathom Pharmaceuticals ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Phathom Pharmaceuticals ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Phathom Pharmaceuticals. 7
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.11 | $-0.21 | $-0.19 | $-0.41 |
| Actual | $0.00 | $-0.18 | $-0.08 | $-0.15 |
| Surprise | +100.0% | +14.3% | +57.9% | +63.4% |
| Revenue | ||||
| Estimate | $73.6M | $56.8M | $57.4M | $47.9M |
| Actual | $74.3M | $58.3M | $57.6M | $49.5M |
| Surprise | +1.01% | +2.66% | +0.26% | +3.41% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.03 | $0.10 |
| Revenue | ||
| Consensus | $85.5M | $98.8M |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $0 | $-0.11 | 100.0 % |
| Q1 | Apr 30, 2026 | $-0.18 | $-0.21 | 14.3 % |
| Q4 | Feb 26, 2026 | $-0.08 | $-0.19 | 57.9 % |
| Q3 | Oct 30, 2025 | $-0.15 | $-0.41 | 63.4 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $74.30M | $73.55M | 1.01 % |
| Q1 | Apr 30, 2026 | $58.30M | $56.79M | 2.66 % |
| Q4 | Feb 26, 2026 | $57.58M | $57.43M | 0.26 % |
| Q3 | Oct 30, 2025 | $49.50M | $47.87M | 3.41 % |